177 related articles for article (PubMed ID: 16842094)
1. Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's.
Wyss-Coray T
Curr Alzheimer Res; 2006 Jul; 3(3):191-5. PubMed ID: 16842094
[TBL] [Abstract][Full Text] [Related]
2. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.
Tesseur I; Zou K; Esposito L; Bard F; Berber E; Can JV; Lin AH; Crews L; Tremblay P; Mathews P; Mucke L; Masliah E; Wyss-Coray T
J Clin Invest; 2006 Nov; 116(11):3060-9. PubMed ID: 17080199
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
Wyss-Coray T
J Mol Neurosci; 2004; 24(1):149-53. PubMed ID: 15314264
[TBL] [Abstract][Full Text] [Related]
4. A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models.
Tesseur I; Wyss-Coray T
Curr Alzheimer Res; 2006 Dec; 3(5):505-13. PubMed ID: 17168649
[TBL] [Abstract][Full Text] [Related]
5. Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection.
Caraci F; Spampinato S; Sortino MA; Bosco P; Battaglia G; Bruno V; Drago F; Nicoletti F; Copani A
Cell Tissue Res; 2012 Jan; 347(1):291-301. PubMed ID: 21879289
[TBL] [Abstract][Full Text] [Related]
6. Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
Hölscher C
Rev Neurosci; 2005; 16(3):181-212. PubMed ID: 16323560
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
Lee HG; Ueda M; Zhu X; Perry G; Smith MA
J Neurosci Res; 2006 Dec; 84(8):1856-61. PubMed ID: 16998902
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of TGF-beta signaling in Alzheimer's disease.
Das P; Golde T
J Clin Invest; 2006 Nov; 116(11):2855-7. PubMed ID: 17080189
[TBL] [Abstract][Full Text] [Related]
9. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease.
Mattson MP; Barger SW; Furukawa K; Bruce AJ; Wyss-Coray T; Mark RJ; Mucke L
Brain Res Brain Res Rev; 1997 Feb; 23(1-2):47-61. PubMed ID: 9063586
[TBL] [Abstract][Full Text] [Related]
10. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
11. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor.
Wang H; Liu J; Zong Y; Xu Y; Deng W; Zhu H; Liu Y; Ma C; Huang L; Zhang L; Qin C
Brain Res; 2010 Oct; 1357():166-74. PubMed ID: 20709030
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain.
Kuhla A; Ludwig SC; Kuhla B; Münch G; Vollmar B
Neurobiol Aging; 2015 Feb; 36(2):753-61. PubMed ID: 25448604
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of ischemic neuronal cell death--with relevance to Alzheimer's disease.
Hayashi T; Shoji M; Abe K
Curr Alzheimer Res; 2006 Sep; 3(4):351-8. PubMed ID: 17017865
[TBL] [Abstract][Full Text] [Related]
14. Transforming Growth Factor Beta Type I Role in Neurodegeneration: Implications for Alzheimer´s Disease.
Estrada LD; Oliveira-Cruz L; Cabrera D
Curr Protein Pept Sci; 2018; 19(12):1180-1188. PubMed ID: 29189146
[TBL] [Abstract][Full Text] [Related]
15. Characterization of V642I-AbetaPP-induced cytotoxicity in primary neurons.
Niikura T; Yamada M; Chiba T; Aiso S; Matsuoka M; Nishimoto I
J Neurosci Res; 2004 Jul; 77(1):54-62. PubMed ID: 15197738
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
Wirths O; Breyhan H; Marcello A; Cotel MC; Brück W; Bayer TA
Neurobiol Aging; 2010 May; 31(5):747-57. PubMed ID: 18657882
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease.
Caraci F; Battaglia G; Bruno V; Bosco P; Carbonaro V; Giuffrida ML; Drago F; Sortino MA; Nicoletti F; Copani A
CNS Neurosci Ther; 2011 Aug; 17(4):237-49. PubMed ID: 19925479
[TBL] [Abstract][Full Text] [Related]
18. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
19. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration.
Salehi A; Delcroix JD; Mobley WC
Trends Neurosci; 2003 Feb; 26(2):73-80. PubMed ID: 12536130
[TBL] [Abstract][Full Text] [Related]
20. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
